Enhance Health vs Instanda: Revenue, Funding & Team Size Compared
Enhance Health generates $69.3M in revenue; Instanda generates $46.5M. Enhance Health is 1.5× bigger than Instanda by revenue. The table below compares Enhance Health and Instanda on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $69.3M | $46.5M |
| Valuation | Not disclosed | $279M |
| Funding raised | Not disclosed | $19.5M |
| Team size | Not disclosed | 220 |
| Founded | 2021 | 2012 |
| HQ | Clearwater, United States | London, United Kingdom |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Enhance Health at a glance
Enhance Health generates $69.3M in revenue, headquartered in Clearwater, United States.
- Revenue
- $69.3M
- Founded
- 2021
A technology-enabled digital health insurance brokerage focused on the Medicare Advantage market.
Instanda at a glance
Instanda generates $46.5M in revenue with 220 employees, headquartered in London, United Kingdom.
- Revenue
- $46.5M
- Valuation
- $279M
- Funding
- $19.5M
- Team size
- 220
- Founded
- 2012
Instanda is a SaaS insurance software platform that allows insurance companies to build, configure, and launch products online.
Other Enhance Health alternatives
Enhance Health competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Enhance Health vs Instanda: frequently asked questions
Is Enhance Health or Instanda bigger?
Enhance Health is the bigger company by revenue, at $69.3M against $46.5M for Instanda.
How much revenue does Enhance Health make?
Enhance Health generates $69.3M in annual revenue.
How much revenue does Instanda make?
Instanda generates $46.5M in annual revenue with a team of 220.
How much funding has Instanda raised?
Instanda has raised $19.5M in total funding since it was founded in 2012.